Autoimmune hepatitis is the most common autoimmune ... Few treatment alternatives are available for refractory AIH. MMF has been frequently used as a treatment alternative for refractory AIH ...
Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...
Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Brist ...
Our partner, Arcellx, Inc. ("Arcellx"), presented new data evaluating investigational anitocabtagene autoleucel ("anito-cel") in relapsed or refractory ("R/R") multiple ... including HIV, viral ...
In the setting of transplantation, rituximab has been used in refractory-B-cell-associated ... is often associated with hepatitis C virus (HCV) infection, and leads to a membranoproliferative ...
A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa in 7 specific patient populations.
Those who are hepatitis B surface antigen-positive are eligible for ... for treating patients with relapsed/refractory DLBCL, as well as in the phase 2 waveLINE-007 trial (NCT05406401) where the agent ...
Current therapies rarely achieve a cure due to the refractory nature of an intracellular viral replication ... potentially curative therapies of chronic hepatitis B. A second key for HBV persistence ...
and is refractory to the current treatments. Given the significant morbidity and mortality associated with chronic hepatitis B, including complications such as liver cirrhosis and hepatocellular ...